Connect with us

Technology

FACTOR X Emerges from Stealth with Novel RNA – based Technology to Transform the Global Beauty Industry

Published

on

FACTOR X is a newly launched longevity-focused beauty technology company developing a breakthrough cellular delivery platform designed to transform the anti-aging skincare industry. Founded by entrepreneur and model Bar Refaeli, longevity physician Dr. Inbal Gat, Harvard-trained scientist Dr. Shira Orr, and health-tech entrepreneur Eran Orr, the company combines world-class scientific expertise with global commercial experience. The company’s proprietary technology enables the precise and safe delivery of active ingredients directly into targeted skin cells, opening the door to next-generation cosmetic products that can stimulate natural hyaluronic acid production, restore hair pigmentation, activate dormant hair follicles, improve skin pigmentation, and support healthier, more youthful skin at the cellular level. Following a successful pre-seed financing round, FACTOR X is currently raising a seed round to accelerate product development, expand strategic partnerships, and establish laboratory operations in Israel alongside its research activities in Boston. The platform is designed for easy integration into existing cosmetic formulations, offering major beauty brands a scalable, room-temperature-stable solution that could redefine the emerging “Skin Longevity” category

TEL AVIV, Israel, July 12, 2026 /PRNewswire-PRWeb/ — FACTOR X, a longevity-focused beauty technology company, today announced its official launch.

Following the successful completion of a pre-seed financing round, the company is now raising a seed round to accelerate development and expand its operations.

FACTOR X was founded by an exceptional team that combines pioneering science, longevity medicine, and global business expertise. The founding team includes international entrepreneur and model Bar Refaeli, longevity physician Dr. Inbal Gat, Harvard-trained scientist Dr. Shira Orr, and serial health-tech entrepreneur Eran Orr.

The company is developing a proprietary cellular delivery platform based on the principles of longevity science that, for the first time, enables the safe and precise delivery of biological payloads such as RNA directly into skin cells. Unlike conventional cosmetic technologies that primarily act on the skin’s surface, FACTOR X aims to fundamentally redefine how anti-aging products work.

The company’s technology combines a proprietary nanoparticle with RNA therapeutics. The nanoparticle protects the RNA as it penetrates the skin and delivers it directly into target cells, where it instructs them to restore youthful biological function. Potential applications include stimulating natural hyaluronic acid production in aging skin, restoring natural hair pigmentation, reactivating dormant hair follicles, reducing pigmentation disorders, and repairing biological aging pathways within skin cells.

FACTOR X was established through the strategic collaboration of three female founders, each contributing unique expertise to transform the global beauty industry.

The company’s clinical vision is led by Dr. Inbal Gat, a physician (DMD) who graduated with Dean’s Honors from Tel Aviv University and became the first Israeli to complete the global longevity medicine program at the American Academy of Anti-Aging Medicine (A4M), earning international certification in functional and longevity medicine. Following more than a decade of clinical practice in aesthetic medicine and extensive research in longevity, Dr. Gat developed her “Skin Longevity” philosophy, combining clinical experience with a deep understanding of the biology of aging.

Joining the team is Dr. Shira Orr, Chief Scientist and Co-Founder, who completed her postdoctoral research at Harvard University. Dr. Orr is leading the development of the company’s proprietary platform, whose nanoparticles transport RNA directly into target skin cells.

Completing the founding team is Bar Refaeli, who brings global visibility, brand recognition, and unparalleled access to international luxury beauty, marketing, media, and distribution networks.

Also joining the leadership team is Eran Orr, Founder and CEO of XRHealth and a recognized serial entrepreneur in digital health and medical devices. XRHealth has raised tens of millions of dollars from international investors and operates one of the world’s leading immersive healthcare platforms.

Dr. Inbal Gat, Co-Founder and Skin Longevity Pioneer

“Throughout my career in aesthetic medicine, I have always searched for ways to rejuvenate the skin from within rather than simply covering it with topical ingredients. FACTOR X applies the most advanced principles of longevity medicine and translates cutting-edge scientific discoveries into products that can communicate directly with skin cells, repair biological dysfunction, and restore youthful cellular activity. That is what true Skin Longevity means.”

Dr. Shira Orr, Co-Founder and Chief Scientific Officer

“Our platform is designed to be completely safe for everyday use, non-toxic, stable as a room-temperature powder, and easily incorporated into virtually any cosmetic formulation. Its precision enables RNA to reach specific target cells such as fibroblasts and stimulate them to produce proteins as they would in biologically younger skin.”

Bar Refaeli, Co-Founder

“Throughout my career, I’ve been exposed to countless beauty products, but FACTOR X represents something fundamentally different. When I learned about the science behind the company, it became clear that this wasn’t simply another cosmetic brand—it is a platform capable of changing the future of the beauty industry. Our vision isn’t to compete with existing brands, but to enable them by integrating our technology into the world’s leading skincare products.”

Currently in the proof-of-concept stage, FACTOR X offers several significant scientific and commercial advantages. Unlike many existing intracellular delivery technologies, which often suffer from toxicity, the FACTOR X platform is designed to be non-toxic and suitable for routine daily use. Its precision targeting allows RNA payloads to reach only intended cells, such as fibroblasts, minimizing off-target effects.

The platform also delivers two major commercial innovations. First, it is stable at room temperature with a long shelf life, eliminating the need for costly cold-chain logistics. Second, the RNA-loaded nanoparticles are manufactured as a stable powder that can be easily incorporated into existing cosmetic products—including creams, serums, and masks—without altering their original formulations.

This capability enables a highly scalable B2B business model, allowing FACTOR X to partner with leading global cosmetics companies without requiring them to redesign existing manufacturing processes, while still preserving the option to develop proprietary consumer products.

Initial proof-of-concept studies have already demonstrated promising technological feasibility. The company is now expanding development efforts and building international strategic partnerships, leveraging the scientific expertise and global reach of its founding team to establish Real Skin Longevity as one of the fastest-growing categories in beauty, longevity, and consumer biotechnology.

Media Contact

Shira Orr, Factor X, 972 9999999, contact@factorx.skin, https://www.factorx.skin/

View original content to download multimedia:https://www.prweb.com/releases/factor-x-emerges-from-stealth-with-novel-rna—based-technology-to-transform-the-global-beauty-industry-302823448.html

SOURCE Factor X

Continue Reading

Technology

WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America

Published

on

By

The Distribution agreement covers the United States and Canada, with sales through the partnership to begin in the U.S.WIM S is available to U.S. consumers online through Ottobock’s direct-to-consumer platform and WIRobotics USA’s online store.U.S. consumers will be able to try WIM S at select orthotic and prosthetic clinics.

SEOUL, South Korea, Nov. 16, 2026 /PRNewswire/ — WIRobotics, a global robotics company led by Co-CEOs Younbaek Lee and Yongjae Kim, announced that its U.S. subsidiary, WIRobotics USA Inc., signed a distribution and sales agreement with Otto Bock HealthCare LP on October 15. Under the agreement, WIRobotics USA will supply WIM S, the company’s wearable mobility robot, and Ottobock will serve as a distribution partner in the United States and Canada.

The partnership will begin in the United States, where consumers will be able to purchase WIM S online through Ottobock’s dedicated direct-to-consumer online platform and WIRobotics USA’s online store, and try the robot initially at select orthotic and prosthetic (O&P) clinics. Based on customer feedback, the companies will consider offering hands-on experiences at more U.S. locations and extending sales through the partnership to Canada. 

The partnership brings together WIRobotics’ wearable robotics technology and Ottobock’s more than 100 years of experience in human mobility. Founded in Germany in 1919, Ottobock has established distribution, clinical care and service networks in the United States and Canada. The companies plan to collaborate on market development, brand building, product training and after-sales service, with WIRobotics USA supporting training and service operations locally.

The agreement marks a major step in WIRobotics’ global expansion. Now in its third year of commercialization, WIM has surpassed 4,000 units in cumulative sales, and the company has expanded sales beyond South Korea to markets including Europe, China and Japan. WIRobotics has been accelerating its international business, with the United States and Canada as key strategic markets. To support this growth, the company established WIRobotics USA Inc. under General Manager Jacob Kim to build local operations in North America.

The companies also see significant opportunities to extend their collaboration to WIM Medi, which WIRobotics is developing for medical use. They view WIM Medi as a natural next step for the partnership, with entry into U.S. and Canadian medical and rehabilitation channels to follow applicable regulatory authorization and a separate agreement.

“Our goal is to make wearable mobility technology easier for people to experience and integrate into everyday life,” said Younbaek Lee, co-CEO of WIRobotics. “Working with Ottobock gives us an opportunity to introduce WIM S to more people across North America. We will expand our engagement with customers in the region and strengthen WIM’s global business foundation.”

“At Ottobock, we are committed to helping people maintain mobility and independence through innovative solutions that support an active lifestyle,” said Scott Schneider, Head of Government/Medical Affairs & Future Development at Ottobock. “WIRobotics is an exceptional company whose technology closely aligns with that vision. Through this partnership, we look forward to introducing WIM S to consumers across North America, beginning with a focused U.S. launch, while exploring new ways for people to experience wearable mobility technology firsthand.“

About WIRobotics
WIRobotics is a global robotics company that develops wearable mobility robots designed to help people move more freely in everyday life. Its WIM series is sold in South Korea and international markets.  Through the development of its ALLEX humanoid robot, the company is also expanding into humanoid robotics and Physical AI. In May 2026, the company raised KRW 95 billion (approximately USD 68 million) in Series B funding to accelerate its global expansion and the commercialization of its robotics technologies. Headquartered in South Korea, the company operates in North America through WIRobotics USA Inc. For more information, visit https://usa.wirobotics.com

About Ottobock
Ottobock, a listed global MedTech champion, combines over 100 years of tradition with outstanding innovative strength in the fields of prosthetics, neuro-orthotics and exoskeletons. Ottobock develops innovative fitting solutions for people with limited mobility and is driving the digitalization of the industry. Founded in Berlin in 1919, the company has business activities in 45 countries with nearly 9,300 employees (FTEs) worldwide and operates the largest international patient care network with more than 430 patient care clinics. Ottobock is shaping the future of human bionics with a strong R&D ratio in the products and components business and over 2,600 patents and patent applications. Ottobock’s mission of improving freedom of movement, quality of life and independence is deeply rooted in the company’s DNA, as is its social commitment: Ottobock has been a partner and supporter of the Paralympics since 1988.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/wirobotics-and-ottobock-join-forces-to-expand-access-to-wearable-robots-across-north-america-302939726.html

SOURCE WIRobotics

Continue Reading

Technology

Ekinops unveils PTM300 compact modular platform for ultra-high-capacity datacenter connectivity

Published

on

By

New 3RU* optical platform delivers up to 32 Tb/s capacity with ultra-low power consumption per bit,  open management and multi-vendor interoperability

PARIS, Nov. 16, 2026 /PRNewswire/ — Ekinops (Euronext Paris – FR0011466069 – EKI), a leading provider of optical networks, connectivity and SASE cybersecurity solutions for telecom service providers and enterprises, today announces the release of PTM300, a new compact modular optical platform designed for high-capacity datacenter interconnect (DCI) and scale-across optical networking applications.

Designed to bring carrier-class optical transport into a datacenter form factor, PTM300 delivers up to 32 Tb/s of client and line capacity in just 3RU, supporting up to 40 x 800 Gb/s coherent pluggable interfaces.

The platform combines ultra-high density and ultra-low 0.08W per Gbps (watts per gigabit per second) power consumption with redundant power and cooling, front-to-back airflow, and Open management interface based on Openconfig and Netconf/Yang for easy integration into open, standards-based environments. It is also compatible with Ekinops’ Celestis NMS for unified network management within an Ekinops optical network further simplifying integration.

With PTM300, Ekinops is extending its optical networking portfolio to address increasing interconnection bandwidth requirements between datacenters with compact modular platforms that seamlessly enable the transition from the telco environment.

High density without compromising openness and performance

PTM300 can be deployed over direct fiber, existing Ekinops optical line systems or third-party infrastructure using alien wavelengths. Beyond DCI, it is designed to address metro, regional and long-haul transport applications as well as service regeneration for router-hosted IPoWDM applications.

*RU = Rack Unit

“The rapid growth of cloud and AI is creating unprecedented bandwidth requirements between data centers, as well a greater demand for service providers to deliver wavelength services to these locations. With PTM300, we are bringing together ultra-high capacity, ultra-low power consumption, operational simplicity and openness in a compact platform designed to help operators scale their optical networks while protecting existing infrastructure investments,” said Philippe Moulin, Chief Operating Officer of Ekinops.

PTM300 will be generally available in December 2026 with first customer deployments expected in Q1 2027.

All press releases are published after Euronext Paris market close.

Ekinops contacts

Lionel Chmilewsky, CEO
contact@ekinops.com

Mathieu Omnes, Investor relation
Tel.: +33 (0)1 53 67 36 92
momnes@actus.fr

Amaury Dugast, Press relation
Tel.: +33 (0)1 53 67 36 74
adugast@actus.fr

For more information, visit https://www.ekinops.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/ekinops-unveils-ptm300-compact-modular-platform-for-ultra-high-capacity-datacenter-connectivity-302940614.html

SOURCE Ekinops

Continue Reading

Technology

Aviemore Launches Seal-Less Magnetic Coupling Pump Platform for Liquid-Cooled AI Data Centers

Published

on

By

Integrated pump, motor and drive built for 800 VDC power and megawatt-class AI racks

CHICAGO, Nov. 16, 2026 /PRNewswire/ — Aviemore Motion Technologies today introduced its seal-less magnetic coupling pumps for liquid-cooled AI and high performance computing at SC26 in Chicago, the international conference for high performance computing. The patent-pending design eliminates the shaft seal, the most common point of wear in a coolant pump. Aviemore delivers the pump, motor and drive as one complete system under a single part number.

Seal-less magnetic coupling pumps with integrated drive, built in Virginia for 800 VDC AI and data center cooling.

AI racks draw 140 kW today. Racks of 240 kW are close behind and 600 kW to megawatt-class racks are in future planning. Power inside the rack is also moving from 54 VDC to 800 VDC, with the first commercial systems expected to ship in Q2 2027. Cooling units built for these racks need pumps that run nonstop, fit in tight spaces and connect directly to high-voltage DC power. Aviemore built its platform for that paradigm shift.

Nearly every watt an AI processor uses turns into heat. Removing that heat is one of the biggest jobs in a data center. Liquid cooling does it far better than air, and the pump is what keeps the coolant moving. Rack and row cooling loops are closed systems. The same coolant circulates over and over instead of being used up, which helps operators cut the water and energy spent on cooling. With no shaft seal, an Aviemore pump keeps that loop closed.

“Liquid cooling is now critical infrastructure and the pump is the one moving part every rack depends on,” said Moe Barani, CEO of Aviemore. “Most pumps on the market were designed for another era and adapted for the data center. We designed ours for where AI infrastructure is going. There is no seal to leak or wear out, the drive runs natively on 800 VDC and our team can turn a custom change in weeks instead of quarters.”

How it works

Aviemore pumps transmit torque through a magnetic coupling across a non-contact sealed barrier. Nothing passes through the wet end. There is no dynamic seal and no wear item in the fluid path. The pumps can run dry during commissioning or a loss of prime, two common causes of early pump failure. A slotless brushless DC motor and integrated drive complete the assembly. CDU builders source, qualify and service one component instead of three.

The platform covers 0.10 to 5.0 kW of output across a 12 to 800 V DC bus range.

Most pumps in data center cooling today come from legacy manufacturers that adapted designs built for other industries. They still rely on a shaft seal, a bolt-on motor and a third-party drive. Their development cycles are measured in years while AI rack designs change every year.

“The traditional pump industry is full of dinosaurs,” said Matt Carroll, VP of Engineering at Aviemore. “They are still selling the same seal, the same separate motor and the same slow change process. Data center operators are left to design around it. We started from a clean sheet. The seal is gone and the motor and drive are built in. When a customer needs a change, our engineering team turns it in weeks.”

Product lines

Rack CDU Pumps: 0.10 to 2.0 kW, 12 to 800 V DC, AC and DC drive, for in-rack and sidecar CDUsRow and Facility Pumps: 1.0 to 5.0 kW, 12 to 800 V DC, AC and DC drive, for row CDUs, coolant skids, and facility loopsOEM Custom Solutions: co-engineered and built to the customer’s architecture, with AC and DC drive options

Proven motor technology, built in Virginia

The Aviemore team has worked together for more than 25 years and has deep experience in data center thermal hardware. Its proprietary slotless motor design has shipped in more than 15,000 motors with zero motor defects. The team has been designing proprietary, patented pumps for the past 20 years and those products remain in service at hyperscale operators today.

Aviemore designs and builds its pumps in a 156,000 square foot facility in Radford, Virginia. Winding, machining, assembly and test all happen in house, which is how the company turns design changes in weeks. The quality system is built on ISO 9001 and products are UL and Intertek certifiable on request.

Data centers are often criticized for bringing few jobs to the towns that host them. Much of the hiring happens in the supply chain that builds the equipment inside. Every Aviemore pump is designed and built in Radford. That supports skilled engineering and manufacturing jobs in Southwest Virginia, and the team grows as AI demand grows.

Aviemore works with Intertek on testing and certification and with Virginia Tech on research. It also partners with the Virginia Economic Development Partnership and GO Virginia on regional industry growth.

Meet Aviemore at SC26

Supercomputing was one of the first fields to adopt direct liquid cooling. The rack densities HPC pioneered are now reaching AI data centers. The Aviemore team is at SC26 in Chicago this week to meet with HPC system builders, thermal engineers and CDU manufacturers. To schedule time or get a pump sized, contact info@aviemoretech.com.

About Aviemore

Aviemore Motion Technologies LLC designs and manufactures seal-less magnetic coupling pumps for liquid-cooled AI and data center infrastructure. Each pump combines the hydraulics, a slotless BLDC motor and an integrated drive in a single assembly. The range covers 0.10 to 5.0 kW and DC bus voltages up to 800 V. Aviemore is headquartered in Radford, Virginia. Learn more at aviemoretech.com.

Media Contact
Ben Khandan-Barani, COO
Aviemore Motion Technologies
info@aviemoretech.com | 540-922-9631
113 Corporate Drive, Radford, VA

View original content to download multimedia:https://www.prnewswire.com/news-releases/aviemore-launches-seal-less-magnetic-coupling-pump-platform-for-liquid-cooled-ai-data-centers-302939792.html

SOURCE Aviemore Motion Technologies

Continue Reading

Trending